Finland· FI-REL-REL12926
Vaniqa
A eflornithine product containing eflornithine, registered in Finland by Almirall SA. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Eflornithine is registered in 12 of 19 countries.
Countries holding a registration under ATC D11AX16 (eflornithine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Eflornithine · ATC D11AX16
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Eflornithine
- Manufacturer
- Almirall SA
- Country
- Finland (FI)
- ATC code
- D11AX16
- ATC class
- Eflornithine
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eflornithine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVANIQAAlmirall, S.A., Barcelona
- United KingdomVaniqa 11.5% creamDE Pharmaceuticals
- SpainVANIQA 11,5 % CREMAAlmirall S.A.
- SwitzerlandIfinwil 192 mg, TablettenNorgine AG
- IrelandVaniqa 11.5%Almirall, S.A.
- NorwayIwilfinUS WorldMeds
- SwedenVaniqa 11,5 % KrämAlmirall S.A.
- BelgiumVaniqa 11.5 %Almirall
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- France · Ornidyl
- Iceland · Vaniqa
- Liechtenstein · Vaniqa
- Norway · Vaniqa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1e1fe6e6-606e-4acd-bdef-29ce57ce64ed GET /v1/drugs/1e1fe6e6-606e-4acd-bdef-29ce57ce64ed?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "emulsiovoide",
"route": "Iholle",
"ddd_unit": null,
"strength": "11.5 %",
"atc_label": "eflornitiini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/01/173/001-003",
"fimea_rel_id": "REL12926",
"authorised_at": "2001-03-20"
}See everything about eflornithine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.